Search - tctmd.com

Displaying 401 - 420 of 504

Sort: Relevancy | Date

News Daily News

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

L.A. McKeown

July 19, 2013

News Daily News

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

L.A. McKeown

July 19, 2013

News Daily News

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

July 19, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Daily News

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

Caitlin E. Cox

July 05, 2013

News Daily News

EnligHTN I Publicado: La Denervación Renal con Catéter Multielectrodo es Segura y Eficaz

Caitlin E. Cox

July 05, 2013

News Daily News

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Jason Kahn

June 28, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Jason Kahn

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

News Industry News

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

June 04, 2013

News Industry News

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

May 23, 2013

News Industry News

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

May 21, 2013

News Daily News

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

L.A. McKeown

May 17, 2013

News Daily News

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

May 17, 2013

News Daily News

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

L.A. McKeown

May 17, 2013

News Daily News

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

May 17, 2013

News Conference News SCAI 2013

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

Yael L. Maxwell

May 09, 2013

News Daily News

Post-TAVR Hypertension Common, Predicts Better Outcomes

May 03, 2013

Advertisement

Heart Rate-Lowering Drug Shows Promise for STEMI Patients After PCI

Un Fármaco Reductor de la Frecuencia Cardíaca resulta Prometedor para Pacientes STEMI tras PCI

La Denervación Renal es Segura y Eficaz contra la Hipertensión Resistente Moderada en un Estudio Piloto

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

EnligHTN I Published: Renal Denervation with Multielectrode Catheter Safe, Effective

EnligHTN I Publicado: La Denervación Renal con Catéter Multielectrodo es Segura y Eficaz

STEMI Marked by Microvascular Dysfunction Linked to Higher Long-term Mortality

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

STEMI marcado por disfunción microvascular vinculado a mayor mortalidad a largo plazo

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

St. Jude Medical Initiates First US Clinical Study of the EnligHTN Renal Denervation System for Drug-Resistant High Blood Pressure

One Year Data from St. Jude Medical Study Demonstrates Safe, Rapid and Sustained Blood Pressure Reduction with EnligHTN Renal Denervation Technology

Medtronic Announces Data From Largest Real-World Patient Population Confirm Strong Safety Profile and Clinical Efficacy of Renal Denervation with the Symplicity(TM) System

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

EVEREST II at 4 Years: Surgery Maintains Early Advantage, But MitraClip Durable

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

EVEREST II a los 4 Años: La Cirugía Mantiene una Ventaja Inicial pero MitraClip es Duradero

POSEIDON: Sliding-Scale Hydration Prevents CIN, Adverse Events at 6 Months

Post-TAVR Hypertension Common, Predicts Better Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content